Silverwood Partners
  • About Us
    • Overview
    • Why Silverwood?
    • Careers
    • Our Location
    • Connect With Us
  • Insights & Analysis
    • Newsletters
    • Intelligence Briefs
    • Events
    • Connect With Us
  • Team
    • All Team
    • Technology
    • Consumer
    • Healthcare
  • Industry Experience
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
  • Services
    • Mergers & Acquisitions
    • Private Placements
    • Connect With Us
  • Transactions
    • All Transactions
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
Select Page
Healthcare Private Placement and M&A Transactions Review Week Ending May 1 2022

Healthcare Private Placement and M&A Transactions Review Week Ending May 1 2022

by Jonathan Hodson-Walker | May 3, 2022 | Healthcare

Strategy | Financing Highlight Private Placement / Financing Transactions OMass Therapeutics: The company raised $100 million of Series B venture funding in a deal led by GV, Sanofi Ventures, and Northpond Ventures on April 28, 2022. Oxford Spin-out Equity Management,...
Healthcare Private Placement and M&A Transactions Review Week Ending April 24 2022

Healthcare Private Placement and M&A Transactions Review Week Ending April 24 2022

by Jonathan Hodson-Walker | Apr 26, 2022 | Healthcare

Strategy | Financing Highlight Private Placement / Financing Transactions Dianthus Therapeutics: The company raised $100 million of venture funding from undisclosed investors on April 19, 2022. The company is a developer of next-generation complement therapeutics...
Healthcare Private Placement and M&A Transactions Review Week Ending April 10 2022

Healthcare Private Placement and M&A Transactions Review Week Ending April 10 2022

by Jonathan Hodson-Walker | Apr 11, 2022 | Healthcare

Strategy | Financing Highlight Private Placement / Financing Transactions Viz.ai: The company raised $100 million of Series D venture funding in a deal co-led by Tiger Global Management and Insight Partners on April 7, 2022, putting the company’s pre-money...
Healthcare Private Placement and M&A Transactions Review Week Ending April 3 2022

Healthcare Private Placement and M&A Transactions Review Week Ending April 3 2022

by Jonathan Hodson-Walker | Apr 4, 2022 | Healthcare

Strategy | Financing Highlight Private Placement / Financing Transactions Aviceda Therapeutics: The company raised $64 million of venture funding from undisclosed investors on March 28, 2022. The company is an operator of a biotech business intended to develop...
Healthcare Private Placement and M&A Transactions Review Week Ending March 27 2022

Healthcare Private Placement and M&A Transactions Review Week Ending March 27 2022

by Jonathan Hodson-Walker | Mar 29, 2022 | Healthcare

Strategy | Financing Highlight Private Placement / Financing Transactions Osso VR: The company raised $66 million of Series C venture funding in a deal led by Oak HC/FT on March 24, 2022, putting the company’s pre-money valuation at $158 million. Kaiser...
Healthcare Private Placement and M&A Transactions Review Week Ending March 20 2022

Healthcare Private Placement and M&A Transactions Review Week Ending March 20 2022

by Jonathan Hodson-Walker | Mar 22, 2022 | Healthcare

Strategy | Financing Highlight Private Placement / Financing Transactions Precirix: The company raised EUR 80 million of Series B venture funding in a deal led by Inkef Capital, Jeito, and Forbion on March 16, 2022. Gimv, HealthCap, Novo Holdings, Pontifax Venture...
« Older Entries
Next Entries »

Search

Recent Posts

  • Technology Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Healthcare Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Technology Private Placement and M&A Transactions Review Week Ending April 27, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending April 27, 2025

Categories

Archives